By: CHRB ARCADIA, CA – The California Horse Racing Board conducted its regular meeting Thursday, April 18, at Santa Anita Park. Chairman Chuck Winner presided. Vice Chair Madeline Auerbach and Commissioners Dennis Alfieri, Fred Maas, Araceli Ruano, and Alex Solis also were in attendance. The audio of this entire Board meeting is available on the
RMTC Updated: ‘Seven Missed Positives’: Indiana Racing Commission Releases Audit Of Truesdail Labs by Edited Press Release The Indiana Horse Racing Commission has released its staff report on the audit of its former primary laboratory – Truesdail Laboratory (Tustin, California). Findings include a total of seven missed positive tests over the twenty-six days in which
By Caryl Williamson NSW trainers say a new rule governing when therapeutic treatment with corticosteroids can be given needs to be reviewed. A rule designed to improve horse welfare is having the opposite effect according to the NSW Trainers Association. From August 1, the Australian Racing Board extended the length of time for the pre-race
NEWS RELEASE March 18, 2014 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD AMENDS ITS LIST OF CONTROLLED THERAPEUTIC MEDICATIONS IN AN EFFORT TO ADVANCE THE REFORM MOVEMENT, COMMITS SIGNIFICANT FUNDS TO 2014 TACTICAL RESEARCH INITIATIVES The board of directors of the Racing Medication and Testing Consortium (RMTC) held a regular meeting March 17 in
NEWS RELEASE December 3, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC: CURRENT THRESHOLD LEVELS FOR CORTICOSTEROIDS, CLENBUTEROL SHOULD REMAIN The Racing Medication & Testing Consortium (RMTC) is releasing two position papers which stated that no physiologic difference among the various racing breeds exists to justify changing regulatory thresholds from those recently established by the
NEWS RELEASE September 20, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC BOARD: STANOZOLOL THRESHOLD ELIMINATED, OHIO STATE LAB GRANTED INTERIM ACCREDITATION, UNIFORM NATIONAL MEDICATION RULES, PENALTIES AND LAB REFORMS ENDORSED, OUT OF COMPETITION TESTING COMMITTEE FORMED, WALDROP ELECTED TO SUCCEED LEWIS AS CHAIRMAN The board of directors of the Racing Medication and Testing Consortium
NEWS RELEASE December 20, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD ANNOUNCES CORTICOSTEROID WITHDRAWAL RECOMMENDATIONS RESULTING FROM ITS CORTICOSTEROID EXPERTS CONFERENCE The Racing Medication and Testing Consortium (RMTC) recently approved minimum withdrawal time recommendations for corticosteroids. These recommendations were based on recently completed work funded in-part by RMTC and conducted at the University of
NEWS RELEASE November 15, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD MAKES THERAPEUTIC WITHDRAWAL RECOMMENDATIONS, ANNOUNCES UPCOMING CORTICOSTEROIDS CONFERENCE At its November 13 meeting in Louisville, Kentucky, the Racing Medication and Testing Consortium (RMTC) board of directors addressed a number of important initiatives including therapeutic medications, laboratory proficiency, corticosteroid regulation and penalties for rule
NEWS RELEASE April 24, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD NAMES INTERIM EXECUTIVE DIRECTOR, RECEIVES UPDATES ON DRUG ADMINISTRATION STUDIES AND MAKES THRESHOLD LEVEL RECOMMENDATION At its April 23 meeting in Dallas, Texas, the Racing Medication and Testing Consortium (RMTC) board of directors approved an agreement with The Jockey Club to engage the
NEWS RELEASE October 10, 2011 Contact: Hallie Lewis (859) 224-2848 or Chris Scherf (410) 392-9200 RACE DAY MEDICATION, DRUG TESTING INITIATIVES AND RESEARCH COMMITTEES PROVIDE UPDATES TO RMTC BOARD At its October 6 meeting in Scottsdale, Arizona, the Racing Medication and Testing Consortium (RMTC) board of directors heard important updates from the race day medication,
SIGN UP TO RECEIVE RMTC COMMUNICATIONS
Quick Links
Sign up to receive RMTC communications:
Sign up to receive RMTC communications:
